Please use this identifier to cite or link to this item:
http://hdl.handle.net/10668/11764
Title: | SEOM clinical guideline in nasopharynx cancer (2017). |
Authors: | Pastor, M Lopez Pousa, A Del Barco, E Perez Segura, P Astorga, B Gonzalez Castelo, B Bonfill, T Martinez Trufero, J Grau, J Jose Mesia, R |
Keywords: | Locally-advanced disease;Nasopharynx cancer;Recurrent/metastatic disease;Treatment guidelines |
metadata.dc.subject.mesh: | Carcinoma Humans Nasopharyngeal Carcinoma Nasopharyngeal Neoplasms |
Issue Date: | 2-Nov-2017 |
Abstract: | Nasopharyngeal carcinoma (NPC) is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to treatment. Radiation therapy is an essential component of curative-intent of non-disseminated disease and the association of chemotherapy improves the rates of survival. In the case of metastatic disease stages, treatment requires platinum/gemcitabine-based chemotherapy and patients may achieve a long survival time. |
URI: | http://hdl.handle.net/10668/11764 |
metadata.dc.identifier.doi: | 10.1007/s12094-017-1777-0 |
Appears in Collections: | Producción 2020 |
Files in This Item:
File | Size | Format | |
---|---|---|---|
PMC5785612.pdf | 347,47 kB | Adobe PDF | View/Open |
This item is protected by original copyright |
This item is licensed under a Creative Commons License